{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-11-21T12:22:46.757588+00:00",
  "news": [
    {
      "title": "Amgen gets a full approval for Imdelltra | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline",
      "link": "https://news.google.com/rss/articles/CBMiggFBVV95cUxOdkdHX3pGYV9IcTN0YjZPMFVTQnpSbldyNjY4czdJcTBILTYyRW1OeklpVFFOb3VFU0JiR1ZZSUdSRnRIXzRBaGFGNTkyend4TURRVWdyejVhcDZORl9DREt5YW1TcXZwTW5zMmlTdDZ4M3p6SmtvUU1VMGJkSm1CSGN3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxOdkdHX3pGYV9IcTN0YjZPMFVTQnpSbldyNjY4czdJcTBILTYyRW1OeklpVFFOb3VFU0JiR1ZZSUdSRnRIXzRBaGFGNTkyend4TURRVWdyejVhcDZORl9DREt5YW1TcXZwTW5zMmlTdDZ4M3p6SmtvUU1VMGJkSm1CSGN3?oc=5\" target=\"_blank\">Amgen gets a full approval for Imdelltra | ApexOnco - Clinical Trials news and analysis</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Oncology Pipeline</font>",
      "published": "2025-11-20T14:57:44+00:00",
      "source": "Oncology Pipeline"
    },
    {
      "title": "Amgen's Imdelltra receives full FDA approval in small cell lung cancer - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMipwFBVV95cUxNVWJKV3hISVpZTnBRXy1pSEdabkN5TnpHa0pCRjdfdEFNeFZRRlRuM2ZkYUxRdG5EY3JtT3lDb21GcHpUMGlLU2JjMHJVdGFRalhTZ0JmRE5oTWVhU2lvTnQxcG9hTTNIUkhYUS1YOTZaeW4zN3FrcFFnejBYaXp3WW40RG5SMU1nblUzb2ZYbklkOC1BelU0QkNiWjhQNjZiOExtUGs2Zw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipwFBVV95cUxNVWJKV3hISVpZTnBRXy1pSEdabkN5TnpHa0pCRjdfdEFNeFZRRlRuM2ZkYUxRdG5EY3JtT3lDb21GcHpUMGlLU2JjMHJVdGFRalhTZ0JmRE5oTWVhU2lvTnQxcG9hTTNIUkhYUS1YOTZaeW4zN3FrcFFnejBYaXp3WW40RG5SMU1nblUzb2ZYbklkOC1BelU0QkNiWjhQNjZiOExtUGs2Zw?oc=5\" target=\"_blank\">Amgen's Imdelltra receives full FDA approval in small cell lung cancer</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-11-19T22:29:33+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "FDA grants full approval for Amgen’s Imdelltra - The Pharma Letter",
      "link": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOV19fRjJrMEJMU1ZUS3d4ZFlYN0E4UDdRUXVMa0h6S2JaMnpTSEhFYW5zTUU1Mkl6NWs1SGF2RUZwYW5yTnB5YndSOG1feE55VWpzOTVINGJSLUVTZF8xV1pUVGRXZDVKQjZTcmxTUDhHODhIS19WWV9pRFkxelpDWG5YMmI2VUNZaGN6UFg0c0hqSVpJVFFv?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMilwFBVV95cUxOV19fRjJrMEJMU1ZUS3d4ZFlYN0E4UDdRUXVMa0h6S2JaMnpTSEhFYW5zTUU1Mkl6NWs1SGF2RUZwYW5yTnB5YndSOG1feE55VWpzOTVINGJSLUVTZF8xV1pUVGRXZDVKQjZTcmxTUDhHODhIS19WWV9pRFkxelpDWG5YMmI2VUNZaGN6UFg0c0hqSVpJVFFv?oc=5\" target=\"_blank\">FDA grants full approval for Amgen’s Imdelltra</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Pharma Letter</font>",
      "published": "2025-11-20T14:37:25+00:00",
      "source": "The Pharma Letter"
    },
    {
      "title": "CEO of drugmaker Amgen talks new results from cholesterol drug trial - CNBC",
      "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNWnIyMTBzWlF3YTBDeVhfYlNYcnZBZ2RzQWpOamRxb3JSZU55MEdrUDRqdzZGT2o3VGNxa05Pc21hUThTZW9pS3lSWmFNWHZfaXJ0YmNodTVXNFhjM2hYZjBWeVpkSlVCakJHczRtOV94aWt2VlJQaU8zQWxCenZvZ1cyVmlJUDJSQUwzd0xZallhcldodk1jUjdnRk5RbkY3VUNPb29fWjLSAa4BQVVfeXFMTndXUncyNjdFRlpKT21TbEFRV2pMY1lDeTdEQ3NNcFlzLV9ScTJJZjFGdDRTWElDbHNGRXkwSkFMVFBxZVFQZzVDRWZmYVlJcEYxOVR6dGtKcEpOVDBlWXRSQVVxSGFnMUxxd2pMaTNmWkZGeTBCMVhGZ0lNbkFzNUlmcGZETUtFTXJkX01qblFRSTFHUG9kV3hVa29yWkNXTjFOZkxuNzY5SjZ6REl3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNWnIyMTBzWlF3YTBDeVhfYlNYcnZBZ2RzQWpOamRxb3JSZU55MEdrUDRqdzZGT2o3VGNxa05Pc21hUThTZW9pS3lSWmFNWHZfaXJ0YmNodTVXNFhjM2hYZjBWeVpkSlVCakJHczRtOV94aWt2VlJQaU8zQWxCenZvZ1cyVmlJUDJSQUwzd0xZallhcldodk1jUjdnRk5RbkY3VUNPb29fWjLSAa4BQVVfeXFMTndXUncyNjdFRlpKT21TbEFRV2pMY1lDeTdEQ3NNcFlzLV9ScTJJZjFGdDRTWElDbHNGRXkwSkFMVFBxZVFQZzVDRWZmYVlJcEYxOVR6dGtKcEpOVDBlWXRSQVVxSGFnMUxxd2pMaTNmWkZGeTBCMVhGZ0lNbkFzNUlmcGZETUtFTXJkX01qblFRSTFHUG9kV3hVa29yWkNXTjFOZkxuNzY5SjZ6REl3?oc=5\" target=\"_blank\">CEO of drugmaker Amgen talks new results from cholesterol drug trial</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CNBC</font>",
      "published": "2025-11-10T08:00:00+00:00",
      "source": "CNBC"
    },
    {
      "title": "Amgen halts gastric cancer trial after antibody 'did not meet our standard' of efficacy, exec says - Fierce Biotech",
      "link": "https://news.google.com/rss/articles/CBMivAFBVV95cUxQLWdIcTFDRGktWXR6N2ZCUUtKSzNTNTRtM3ZqQ2UwdmpuODc4VklpTTNkSFhRTE9jTE9sNFFmam9oZGJwelhfYVBseFJTVlJLOE1ocExaVlhRNHhhRmVrbkRWWXFrYjJpUVVoXzhhOHhvcVhaZTJmMU5lcW9jY3U3UkVjaFNUSk5MMTk5c0tzQXJ1bkRYbUxPWkdtN1JCX2hhQ2c4aGN4ZDJndWFubmJPd1JlNTdKUGNzdWhkVw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivAFBVV95cUxQLWdIcTFDRGktWXR6N2ZCUUtKSzNTNTRtM3ZqQ2UwdmpuODc4VklpTTNkSFhRTE9jTE9sNFFmam9oZGJwelhfYVBseFJTVlJLOE1ocExaVlhRNHhhRmVrbkRWWXFrYjJpUVVoXzhhOHhvcVhaZTJmMU5lcW9jY3U3UkVjaFNUSk5MMTk5c0tzQXJ1bkRYbUxPWkdtN1JCX2hhQ2c4aGN4ZDJndWFubmJPd1JlNTdKUGNzdWhkVw?oc=5\" target=\"_blank\">Amgen halts gastric cancer trial after antibody 'did not meet our standard' of efficacy, exec says</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Biotech</font>",
      "published": "2025-11-05T08:00:00+00:00",
      "source": "Fierce Biotech"
    },
    {
      "title": "Amgen Raises Full-Year Outlook After Third-Quarter Profit, Sales Jump - The Wall Street Journal",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuwNBVV95cUxORk9tbzdSUDlkSWJHWUQ1U3ljS095ODdYN2VRaUxINFYxN0l4azNHVy1nYTJJM2h0QUFwNXBVN05YVUFRVGdGeURzdzhiZ2NhbFdodmRCNHZIUExsZllkVHNtQkRYVVNadWdQU1lnWVJVOUdYNk1RVWNSbVdOSC1jdml6bmxBV09pd0F4SG1vcE5ya2RvTko4bTN3dGNkSmN0aGtPUHBsdjBZX3ZRcUtvbWlUaDFmTkYxeHdtN1E1SmdSM1VWeTJxMEJaNDIwQW9jRE1WTWQ0OGZKTkpZaWw3MGFuTzBlUkdIQ2JFcUM3UFBuM01EWERqM2E0OUM3RnZRdjR1U3kwalMyT0E3M2hlVkQ5N3kybjFoTC1mc0JYWW42QzE1ZXJRMENyTEE1Nl9ycFhKOFMzaGN0MEQ3djNIeGxxdHFCdzNRN0ZwTGV0ZWhQZmtFeGVHeXBmTWp0SmRUXzdoWnFZOVM4eDVzRUNrNm1kd2IyU0JST25xaUNsRGxtT05pWDViR2ktOWlQdUVxbG9zV2xkR3E5ZkxQLUgyQnBKLWFweXpJcklidzJkUDVOVkJpdjRmMVVvTQ?oc=5\" target=\"_blank\">Amgen Raises Full-Year Outlook After Third-Quarter Profit, Sales Jump</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Wall Street Journal</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "The Wall Street Journal"
    },
    {
      "title": "Amgen cholesterol drug cuts risk of first cardiac event by 25% - Reuters",
      "link": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNNkhFaTFGNTVnS01wamZXLXpITVFSMV9wN0ZhWktwRlZZMDhsOTM2cGo4aHlOdGhhSjhONEZtbjdBT3UybERoT1NvQjlYYWpoeERsNGZMcmstSFlMT2ROTmlvUjN3NnBLZm1teUhjekpsNGp1d0o3bmZ6bzNURWVkMnU5RnlhWlRrNFBSSzVvSEt2NDJiMDJQODBlbll3T05zRElMN3BEbmVfd28xaGE5bUZOWnJxSGQ2M29UVDJLV0Nra2hoNTBhZjFB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiygFBVV95cUxNNkhFaTFGNTVnS01wamZXLXpITVFSMV9wN0ZhWktwRlZZMDhsOTM2cGo4aHlOdGhhSjhONEZtbjdBT3UybERoT1NvQjlYYWpoeERsNGZMcmstSFlMT2ROTmlvUjN3NnBLZm1teUhjekpsNGp1d0o3bmZ6bzNURWVkMnU5RnlhWlRrNFBSSzVvSEt2NDJiMDJQODBlbll3T05zRElMN3BEbmVfd28xaGE5bUZOWnJxSGQ2M29UVDJLV0Nra2hoNTBhZjFB?oc=5\" target=\"_blank\">Amgen cholesterol drug cuts risk of first cardiac event by 25%</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-11-08T08:00:00+00:00",
      "source": "Reuters"
    },
    {
      "title": "Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices - The New York Times",
      "link": "https://news.google.com/rss/articles/CBMikwFBVV95cUxPOGtMT0RzU0RhVGtHcjRGc1ZveDNZOUJLMGh3eVB2S3Eyb21tSUpmczRHUEtmWUYtdnlXVGNFUHN6RUVNa3BtZGNGcG1zVEJaZEZUdi03R2R4VHVENzBxcjhrektwRTNFOWpOSTZuSzFpbkRWZktQeDROQkdiV0RCcnBpRFljTDRXSkhWbklkZFhNLW8?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikwFBVV95cUxPOGtMT0RzU0RhVGtHcjRGc1ZveDNZOUJLMGh3eVB2S3Eyb21tSUpmczRHUEtmWUYtdnlXVGNFUHN6RUVNa3BtZGNGcG1zVEJaZEZUdi03R2R4VHVENzBxcjhrektwRTNFOWpOSTZuSzFpbkRWZktQeDROQkdiV0RCcnBpRFljTDRXSkhWbklkZFhNLW8?oc=5\" target=\"_blank\">Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Prices</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The New York Times</font>",
      "published": "2025-11-03T08:00:00+00:00",
      "source": "The New York Times"
    }
  ],
  "product_launches": [
    {
      "title": "Biosimilars referencing Amgen’s Neulasta and Neupogen launch in Canada and US - Generics and Biosimilars Initiative",
      "link": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPbnVybHpDRTRJOEZIM3NmLXBqaHI1LXVXbUMwNS1LTmY4WlFRYUxvUFFrdXdxdmhoeGg1Zm43b3lGMEpSYUFzVVA3emZDNXloUjhNcS1NWHJkTlB2V2FqeGtEQ182RjFTM2M3X0xkazc4c2FyNGRzWGVPSGhtYXlqUjM2MmR4bWg1aGkxNjhnTl9PbS1KbE1wY3dQYTNFTlZ5bjNjOTBNRkZvNDlkSGh0SmNBSkZiTHJP?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPbnVybHpDRTRJOEZIM3NmLXBqaHI1LXVXbUMwNS1LTmY4WlFRYUxvUFFrdXdxdmhoeGg1Zm43b3lGMEpSYUFzVVA3emZDNXloUjhNcS1NWHJkTlB2V2FqeGtEQ182RjFTM2M3X0xkazc4c2FyNGRzWGVPSGhtYXlqUjM2MmR4bWg1aGkxNjhnTl9PbS1KbE1wY3dQYTNFTlZ5bjNjOTBNRkZvNDlkSGh0SmNBSkZiTHJP?oc=5\" target=\"_blank\">Biosimilars referencing Amgen’s Neulasta and Neupogen launch in Canada and US</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Generics and Biosimilars Initiative</font>",
      "published": "2025-11-21T06:21:31+00:00",
      "source": "Generics and Biosimilars Initiative"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "AMGN Q3 Deep Dive: Broad-Based Product Momentum and Pipeline Progress Drive Upbeat Guidance - TradingView",
      "link": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNN09XMkFVU05lZ0ZfVnZnbzkzU3NuNklBWEhsUWtkbVpTOHhHVHEzbk5PSEpGVEY1dUFjLTFLY3U5ZUg1RlhWZm1MR2hqNEd2ZWotTmx5T20wZjhseDBNcTdkdXlELXJvZjRZUVpDR1VXYTdtWmxHX3ZRLXFnRFBIb3VfWk4wSk5fV0ZoNGVSNFNhbkZqUHBhZXc2a0lQZ2Exa2w4eVJZakRFSk5uczBZcmJvSnlXVWRVNHQyV1M0MDZXd2l6X3dFbk5ua0p2UE1VUV9HV0xFS1ppLXZEdFJmRllmR1A1QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi5gFBVV95cUxNN09XMkFVU05lZ0ZfVnZnbzkzU3NuNklBWEhsUWtkbVpTOHhHVHEzbk5PSEpGVEY1dUFjLTFLY3U5ZUg1RlhWZm1MR2hqNEd2ZWotTmx5T20wZjhseDBNcTdkdXlELXJvZjRZUVpDR1VXYTdtWmxHX3ZRLXFnRFBIb3VfWk4wSk5fV0ZoNGVSNFNhbkZqUHBhZXc2a0lQZ2Exa2w4eVJZakRFSk5uczBZcmJvSnlXVWRVNHQyV1M0MDZXd2l6X3dFbk5ua0p2UE1VUV9HV0xFS1ppLXZEdFJmRllmR1A1QQ?oc=5\" target=\"_blank\">AMGN Q3 Deep Dive: Broad-Based Product Momentum and Pipeline Progress Drive Upbeat Guidance</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TradingView</font>",
      "published": "2025-11-05T08:00:00+00:00",
      "source": "TradingView"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-11-20",
      "close": 336.07000732421875
    },
    "history": [
      {
        "date": "2025-11-12",
        "close": 336.2799987792969
      },
      {
        "date": "2025-11-13",
        "close": 336.0
      },
      {
        "date": "2025-11-14",
        "close": 336.739990234375
      },
      {
        "date": "2025-11-17",
        "close": 341.7099914550781
      },
      {
        "date": "2025-11-18",
        "close": 343.989990234375
      },
      {
        "date": "2025-11-19",
        "close": 342.3999938964844
      },
      {
        "date": "2025-11-20",
        "close": 336.07000732421875
      }
    ],
    "name": "Amgen Inc."
  }
}